Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Nguyen

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Cancer Immunology Research|July 12, 2019
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial ImmunotherapyKarin L Lee, Stephen C Benz, Kristin C Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CTSherrington Li, Andrew Nguyen, William Counter, et al.
Therapeutic Advances in Medical Oncology|March 6, 2023
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)Louise Emmett, Nikeith John, Sarennya Pathmanandavel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617: A Single-Center Retrospective StudyVishnu Murthy, Koichiro Kimura, Lela Theus, et al.
European Urology Oncology|August 8, 2020
Phase I/II Trial of the Combination of <sup>177</sup>Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)Megan Crumbaker, Sarennya Pathmanandavel, Andrew O Yam, et al.
JACC. Heart Failure|November 9, 2023
Impact of Digital Health Technology on Quality of Life in Patients With Heart FailureAngela M Victoria-Castro, Melissa L Martin, Yu Yamamoto, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2013
2-dimensional transition metal dichalcogenides with tunable direct band gaps: MoS₂(₁-x) Se₂x monolayersJohn Mann, Quan Ma, Patrick M Odenthal, et al.
BMC Gastroenterology|March 8, 2020
The effect of prophylactic hemoclips on the risk of delayed post-endoscopic mucosal resection bleed for upper and lower gastrointestinal lesions: a retrospective cohort studyKaren Chang, Brian S Lee, Timnit Tekeste, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
3-Year Freedom from Progression After <sup>68</sup>Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter TrialLouise Emmett, Reuben Tang, Rohan Nandurkar, et al.
ACS Nano|April 2, 2014
Postgrowth tuning of the bandgap of single-layer molybdenum disulfide films by sulfur/selenium exchangeQuan Ma, Miguel Isarraraz, Chen S Wang, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Cancer Immunology Research|July 12, 2019
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial ImmunotherapyKarin L Lee, Stephen C Benz, Kristin C Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CTSherrington Li, Andrew Nguyen, William Counter, et al.
Therapeutic Advances in Medical Oncology|March 6, 2023
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)Louise Emmett, Nikeith John, Sarennya Pathmanandavel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617: A Single-Center Retrospective StudyVishnu Murthy, Koichiro Kimura, Lela Theus, et al.
European Urology Oncology|August 8, 2020
Phase I/II Trial of the Combination of <sup>177</sup>Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)Megan Crumbaker, Sarennya Pathmanandavel, Andrew O Yam, et al.
JACC. Heart Failure|November 9, 2023
Impact of Digital Health Technology on Quality of Life in Patients With Heart FailureAngela M Victoria-Castro, Melissa L Martin, Yu Yamamoto, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2013
2-dimensional transition metal dichalcogenides with tunable direct band gaps: MoS₂(₁-x) Se₂x monolayersJohn Mann, Quan Ma, Patrick M Odenthal, et al.
BMC Gastroenterology|March 8, 2020
The effect of prophylactic hemoclips on the risk of delayed post-endoscopic mucosal resection bleed for upper and lower gastrointestinal lesions: a retrospective cohort studyKaren Chang, Brian S Lee, Timnit Tekeste, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
3-Year Freedom from Progression After <sup>68</sup>Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter TrialLouise Emmett, Reuben Tang, Rohan Nandurkar, et al.
ACS Nano|April 2, 2014
Postgrowth tuning of the bandgap of single-layer molybdenum disulfide films by sulfur/selenium exchangeQuan Ma, Miguel Isarraraz, Chen S Wang, et al.
Pageof 25